2019 Community Oncology Conference
CLINICAL TRACKPacific C |
BUSINESS TRACKPacific B |
PHARMACY TRACKPacific A |
ADVOCACY TRACKAtlantic A |
WEDNESDAY, APRIL 3, 2019 |
| 5:30 – 7:00 PM | Registration & President’s Reception |
THURSDAY, APRIL 4, 2019 |
| 6:30 – 7:30 AM | Registration & Buffet Breakfast in the Exhibit Hall | |||
| 7:30 – 7:50 AM | Conference Opening Day One: Welcome from the Co-Chairs | |||
| 7:55 – 8:40 AM | Artificial Intelligence Applications in Community Oncology | CPAN Welcome & Opening Session | ||
| 8:45 – 9:30 AM |
Cyber Liability: How to Protect Your Practice Against Cybercrime
|
From A to D: Understanding Medicare Programs & Terms | ||
| 9:40 – 10:30 AM | KEYNOTE: FIGHT ON Shelley M. Smith, ESPN Correspondent & Jake Olson, Former USC Long Snapper |
|||
| 10:30 – 10:55 AM | Meet & Greet in the Exhibit Hall | |||
| 11:00 – 11:45 AM | What is New & Exciting in AML | From OCM 1.0 to 2.0: Two Paths to Payment Reform | Transforming In-Office Dispensing Pharmacies into Medically Integrated Dispensing |
Clinical Trials in the Community Setting: How Community Oncology is Shaping the Future of Cancer Care |
| 11:50 – 12:35 PM | The Value of Proton Therapy in Cancer Treatment | Oncology Payment Reform: Update on Novel Practice & Payer Models | Latest Advances & Updates: Integrative Medicine for Pharmacists | Cost Drivers of Cancer Care: The Value of Community Oncology & Site of Service |
| 12:35 – 1:30 PM | Lunch & Networking in the Exhibit Hall | |||
| 1:30 – 2:30 PM | Malpractice Litigation in the Era of Health Care Transformation |
Current & Proposed Medicare Reimbursement Changes: Update from the Code Mistress |
COPA Round Table Discussion (Closed Session – Medical Professionals & Staff Only) | The Clash of DC Policy & the Realities of Local Cancer Care |
| 2:35 – 3:20 PM | Clinical Trials: The Basket Deserving of All of the Eggs, A Perspective from a Solo Oncologist | Sit in My Chair: Reaching Your Federal Policymakers Locally | ||
| 3:20 – 3:50 PM | Networking Break | |||
| 3:50 – 4:35 PM | Next Generation Sequencing & Oral Oncolytics | The Employer Perspective on Cancer Care | (Pharmacy in Clinical Track) | What is the Oncology Care Model & Why Does it Matter? What Patients & Survivors Need to Know |
| 4:40 – 5:30 PM | New Novel Ventures & Consolidation in Community Oncology | CLOSED SESSION: CPAN CHAPTER LEADERS ONLY | ||
| 5:30 – 6:30 PM | Networking & Refreshments in the Exhibit Hall | |||
FRIDAY, APRIL 5, 2019 |
| 6:30 – 7:30 AM | Registration & Buffet Breakfast in the Exhibit Hall | |||
| 7:30 – 8:00 AM | Conference Opening Day Two: Update from the Co-Chairs | |||
| 8:00 – 8:45 AM | Update on How Pharmacy Benefit Managers are Adversely Impacting Cancer Care | |||
| 8:45 – 9:45 AM | Legislative Update from Capitol Hill | |||
| 9:45 – 10:10 AM | Break & Networking in the Exhibit Hall | |||
| 10:10 – 11:00 AM | The Industry Perspective: Addressing the Price, Cost & Value of Cancer Drugs | Your Cancer Care Team: Behind the Scenes at a Community Oncology Practice | ||
| 11:05 – 11:50 AM | Latest Advances & Updates in Lung Cancer | Step Therapy & Utilization Management: Medicine & Politics Converge | Legal Issues Affecting Physician Dispensing & Pharmacies: Staying Ahead of Payor & Regulatory Trends | Takeaway Lessons from Successful CPAN Chapters: Superstar Panel |
| 11:50 – 12:50 PM | Lunch & Networking in the Exhibit Hall | |||
| 12:50 – 1:35 PM | CAR-T: Exploring Clinical Efficacy & Toxicity, Value Assessment, Reimbursement Issues & Challenges | Marketing Your Clinic: Referral Building, Patient Experience, Branding, Advertising & Public Relations | Impact of USP <797>/<800> on Community Oncology Practices | All Politics is Local: The Importance of State Level Advocacy |
| 1:40 – 2:25 PM | The Era of Biosimilars: Clinical & Reimbursement Issues & Challenges | Lean Management Utilizing Six Sigma: Overview & Real-World Applications in Community Oncology | Medical Marijuana: Uses in Cancer Treatment | Advocate Networking Session & Photo Opportunities |
| 2:30 – 2:50 PM | Conference Wrap-up: Meeting Observation from the Co-Chairs & Audience | |||
